NCT06315322: A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
- State
- Under way
- Phase
- Phase 3
- People
- 70 taking part
- Started
- 10 Jul 2024
- Primary completion
- 16 Nov 2029
- Arms
- Brivaracetam arm
- Results
- None posted
- 18 Mar 2024: Trial registered
- 10 Jul 2024: Trial started